Forest Labs Inc (NYSE:FRX)

CAPS Rating: 3 out of 5

The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter.

Results 1 - 20 of 71 : 1 2 3 4 Next »

Recs

0
Member Avatar Teacherman333 (24.38) Submitted: 5/15/2013 11:18:17 AM : Outperform Start Price: $38.15 FRX Score: +1.54

For reference point and to allow for comments by others. As of the end of March, 2013.

ROE 0.57%
Trailing PE N/A
PB 1.82
Div yield N/A

Recs

0
Member Avatar scrubs62074 (80.05) Submitted: 2/20/2013 10:59:26 AM : Outperform Start Price: $36.50 FRX Score: -0.77

Bullish MACD crossover on 02/20/13

Recs

0
Member Avatar frankposting (< 20) Submitted: 10/29/2012 11:42:41 AM : Underperform Start Price: $34.63 FRX Score: +3.23

Best sellers are facing patent cliff and most of other products are competing with existing effective and safe generics.

Recs

0
Member Avatar ronmey50 (< 20) Submitted: 9/9/2012 12:21:49 PM : Outperform Start Price: $35.59 FRX Score: -4.42

Icahn will be working from within to unlock the value that is already there.

Recs

0
Member Avatar virtualkcscreen (< 20) Submitted: 9/5/2012 2:18:23 AM : Outperform Start Price: $35.11 FRX Score: -5.43

carl icahn

Recs

0
Member Avatar RugbyViking13 (90.47) Submitted: 8/15/2012 6:48:23 PM : Outperform Start Price: $33.68 FRX Score: -0.64

Drug companies always find a way

Recs

0
Member Avatar Fish08 (43.02) Submitted: 5/21/2012 2:10:17 PM : Outperform Start Price: $33.52 FRX Score: -8.78

Good firm available for less than 10x anuual R&D and a PE of 18.

Recs

0
Member Avatar benyboy (< 20) Submitted: 4/14/2012 5:49:50 AM : Outperform Start Price: $33.52 FRX Score: -2.89

0 debt

Recs

0
Member Avatar stationfool (22.91) Submitted: 1/26/2012 12:03:48 PM : Outperform Start Price: $31.53 FRX Score: -0.57

no debt

Recs

0
Member Avatar shake656 (53.34) Submitted: 11/7/2011 5:38:11 PM : Outperform Start Price: $30.66 FRX Score: -2.29

Under priced.

Recs

0
Member Avatar gravmic (65.22) Submitted: 5/16/2011 3:41:13 PM : Outperform Start Price: $31.54 FRX Score: -6.21

magic formula

Recs

0
Member Avatar hoboinvest (34.81) Submitted: 4/8/2011 11:25:28 PM : Outperform Start Price: $32.98 FRX Score: -5.34

One word, MRSA. They have the drug to fight it.

Recs

0
Member Avatar jemsa (< 20) Submitted: 3/28/2011 1:01:09 PM : Outperform Start Price: $31.01 FRX Score: +0.87

Value Stocks Screen Multiple Ratios

Recs

0
Member Avatar sandeeparoras (58.66) Submitted: 12/9/2010 5:34:07 AM : Outperform Start Price: $32.13 FRX Score: -11.33

Technical Indicator: LCR-20

Recs

0
Member Avatar H20jo52 (70.52) Submitted: 10/15/2010 10:03:57 AM : Outperform Start Price: $33.27 FRX Score: -23.04

patents that it holds

Recs

0
Member Avatar bobmacmaster (< 20) Submitted: 10/10/2010 11:11:33 AM : Outperform Start Price: $31.89 FRX Score: -18.61

This company has carved out a profitable niche

Recs

0
Member Avatar cashman79 (44.55) Submitted: 9/15/2010 9:55:36 AM : Outperform Start Price: $30.68 FRX Score: -19.20

watch

Recs

0
Member Avatar citizenryan (79.44) Submitted: 8/17/2010 6:34:46 PM : Outperform Start Price: $27.99 FRX Score: -10.75

This is the one of the the hardest stock to predict. Lexapro is the 2nd most prescribed drug in America. Government rules regarding patents mean the drug will go generic in 2012. This means FRX's major revenue stream will dry up.

In 2011 people will start selling. Until then it's do well.

With no end in sight for the recession people will continue to be depressed and doctors will prescribe anti-depressant. There is plenty of research on the relationship between recessions (or future outlooks) and depression

Recs

1
Member Avatar dsp444 (79.22) Submitted: 7/23/2010 1:15:00 PM : Outperform Start Price: $28.14 FRX Score: -11.07

On 30 stocks over $50 million market cap magic formula screen

owned for the past year as part of my Magic Formula portfolio. I should be selling it this month, but it is still showing up on the Magic Formula screen. Lots of cash flow and a big cash hoard with no debt. The question is what are they going to do with all that money. There was a new share repurchase program approved by the board in May 2010 for 50 million shares, but there is not plan on when to carry that out. Earnings have been weakening the past couple of years, but I see no big reason to sell, so I will hold onto this stock for another year with my real money Magic Formula portfolio.

Recs

0
Member Avatar cibient (< 20) Submitted: 6/10/2010 2:49:55 PM : Outperform Start Price: $25.72 FRX Score: +0.48

MFI Top 50, amazing balance sheet, $500M stock buyback program.

Results 1 - 20 of 71 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement